Should biomarkers [and Pharma] drive Alzheimer’s diagnosis?
This news item by Alicia Ault was published in Medscape, 27 January 2025:
Tag: anti-amyloid drugs
Anti-amyloid drugs: Key questions
As published here.
Accelerated approval of anti-amyloid drugs
I fully share the concerns expressed by Professor Robert Howard:
Dementia’s Medical-Industrial-Charity Complex
A BMJ rapid response: Personal comment: I fully share the concerns set out in this BMJ response. Alas, Scotland seems to be all set to ‘go’: Keynote Lecture, 2023 for … Continue reading Dementia’s Medical-Industrial-Charity Complex
Blazing trails or the road to nowhere?
As published in the BMJ, 22 August 2023:
Keynote Lecture: Alzheimer Scotland: Annual Conference 2023
Session 3: ‘Looking to a brighter future’ – how today’s research, learning and developments are offering hope for tomorrow. Hilary Evans, Chief Executive of Alzheimer’s Research UK and Co-Chair of … Continue reading Keynote Lecture: Alzheimer Scotland: Annual Conference 2023
“The hyperbole in the media and scientific response is unjustified and cruel to patients”
The following serious concerns, as reported in the BMJ, 22 July 2023, hardly seemed to appear in the worldwide trailblazing headlines of the latest anti-amyloid drug. I wonder why?
Joint Letter by Alzheimer’s Scientists
The following Experts signed this letter [their competing interests can be read here]